SEC takes enforcement action against IGC for claims made about cannabis-based treatment for Alzheimer’s symptoms

The Securities and Exchange Commission has imposed a cease-and-desist order against India Globalization Capital and its founder and chief executive for claims made by the company in 2018 regarding what it described as a cannabis-based product aimed at treating symptoms of Alzheimer’s disease.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.